Home › Funds › NAVELLIER & ASSOCIATES INC › INDV
NAVELLIER & ASSOCIATES INC position in INDV
INDIVIOR PHARMACEUTICALS INC · Health Care
NAVELLIER & ASSOCIATES INC reported holding 180,229 shares of INDV (INDIVIOR PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$6.5M, representing 0.54% of its reported portfolio and ranking #43 among its reported holdings. NAVELLIER & ASSOCIATES INC has disclosed INDV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How NAVELLIER & ASSOCIATES INC's INDV position evolved
NAVELLIER & ASSOCIATES INC first disclosed a stake in INDV in Q4 2025 at 114,904 shares (US$4.1M). The position peaked in Q2 2026 at 173,860 shares, worth US$7.1M. Across 4 filings, NAVELLIER & ASSOCIATES INC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 180,229 shares valued at US$6.5M — an increase of 6,369 shares quarter over quarter.. Notable position changes include a 30% increase in Q2 2026 (shares fell 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 114.90K | $4.12M | New |
| Q1 2026 | 134.11K | $4.09M | Add |
| Q2 2026 | 173.86K | $7.13M | Add |
| Q3 2026 | 180.23K | $6.46M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About INDV and 13F data
INDV (INDIVIOR PHARMACEUTICALS INC) is a Health Care company. 51 other funds we track also report a position in INDV — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), Two Seas Capital LP (US$131.6M), Madison Avenue Partners, LP (US$117.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INDV
- OAKTREE CAPITAL MANAGEMENT LP 6.13M sh · $251.40M · Q2 2026
- Two Seas Capital LP 3.67M sh · $131.61M · Q3 2026
- Madison Avenue Partners, LP 2.87M sh · $117.94M · Q2 2026
- MANGROVE PARTNERS IM, LLC 2.68M sh · $109.83M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.65M sh · $67.65M · Q2 2026
- Jones Hill Capital LP 1.53M sh · $54.73M · Q3 2026
- Newtyn Management, LLC 1.31M sh · $53.58M · Q2 2026
- GENDELL JEFFREY L 1.10M sh · $44.98M · Q2 2026
- Soleus Capital Management, L.P. 1.06M sh · $43.66M · Q2 2026
- Claret Asset Management Corp 685.52K sh · $28.13M · Q2 2026
- Westchester Capital Management, LLC 775.86K sh · $27.81M · Q3 2026
- Divisadero Street Capital Management, LP 601.86K sh · $24.69M · Q2 2026
More on NAVELLIER & ASSOCIATES INC
FAQ
How long has NAVELLIER & ASSOCIATES INC held INDV?
NAVELLIER & ASSOCIATES INC has disclosed INDV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is NAVELLIER & ASSOCIATES INC's current position in INDV?
As of Q3 2026, NAVELLIER & ASSOCIATES INC holds 180.23K shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $6.46M, representing 0.54% of its reported portfolio and ranking #43.
Has NAVELLIER & ASSOCIATES INC been buying or selling INDV?
In the latest 13F filing (Q3 2026), NAVELLIER & ASSOCIATES INC increased its position in INDV. The position peaked in Q2 2026 at 173.86K shares.
Which other funds hold INDV?
Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, Two Seas Capital LP, Madison Avenue Partners, LP, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.